I fase II- forsøget kunne de patienter, som ikke havde en optimal respons på behandlingen med VELCADE alene, få højdosis dexamethason sammen med VELCADE (se tabel 9).
In the Phase II study, patients who did not obtain an optimal response to therapy with VELCADE alone were able to receive high-dose dexamethasone in conjunction with VELCADE (see Table 9).